288 related articles for article (PubMed ID: 29587799)
1. HLA alleles modulate EBV viral load in multiple sclerosis.
Agostini S; Mancuso R; Guerini FR; D'Alfonso S; Agliardi C; Hernis A; Zanzottera M; Barizzone N; Leone MA; Caputo D; Rovaris M; Clerici M
J Transl Med; 2018 Mar; 16(1):80. PubMed ID: 29587799
[TBL] [Abstract][Full Text] [Related]
2. Combining HLA-DR risk alleles and anti-Epstein-Barr virus antibody profiles to stratify multiple sclerosis risk.
Strautins K; Tschochner M; James I; Choo L; Dunn DS; Pedrini M; Kermode A; Carroll W; Nolan D
Mult Scler; 2014 Mar; 20(3):286-94. PubMed ID: 23886832
[TBL] [Abstract][Full Text] [Related]
3. Antibody response to common viruses and human leukocyte antigen-DRB1 in pediatric multiple sclerosis.
Waubant E; Mowry EM; Krupp L; Chitnis T; Yeh EA; Kuntz N; Ness J; Belman A; Milazzo M; Gorman M; Weinstock-Guttman B; Rodriguez M; James JA
Mult Scler; 2013 Jun; 19(7):891-5. PubMed ID: 23232601
[TBL] [Abstract][Full Text] [Related]
4. Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis.
Lünemann JD; Edwards N; Muraro PA; Hayashi S; Cohen JI; Münz C; Martin R
Brain; 2006 Jun; 129(Pt 6):1493-506. PubMed ID: 16569670
[TBL] [Abstract][Full Text] [Related]
5. Gender influence in EBV antibody response in multiple sclerosis patients from Kuwait.
Al-Temaimi R; Alroughani R; Jacob S; Al-Mulla F
J Neuroimmunol; 2015 Aug; 285():57-61. PubMed ID: 26198919
[TBL] [Abstract][Full Text] [Related]
6. Current and past Epstein-Barr virus infection in risk of initial CNS demyelination.
Lucas RM; Ponsonby AL; Dear K; Valery P; Pender MP; Burrows JM; Burrows SR; Chapman C; Coulthard A; Dwyer DE; Dwyer T; Kilpatrick T; Lay ML; McMichael AJ; Taylor BV; van der Mei IA; Williams D
Neurology; 2011 Jul; 77(4):371-9. PubMed ID: 21753179
[TBL] [Abstract][Full Text] [Related]
7. Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis.
Levin LI; Munger KL; Rubertone MV; Peck CA; Lennette ET; Spiegelman D; Ascherio A
JAMA; 2005 May; 293(20):2496-500. PubMed ID: 15914750
[TBL] [Abstract][Full Text] [Related]
8. Integrating risk factors: HLA-DRB1*1501 and Epstein-Barr virus in multiple sclerosis.
De Jager PL; Simon KC; Munger KL; Rioux JD; Hafler DA; Ascherio A
Neurology; 2008 Mar; 70(13 Pt 2):1113-8. PubMed ID: 18272866
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus and multiple sclerosis: interaction with HLA.
Sundqvist E; Sundström P; Lindén M; Hedström AK; Aloisi F; Hillert J; Kockum I; Alfredsson L; Olsson T
Genes Immun; 2012 Jan; 13(1):14-20. PubMed ID: 21776012
[TBL] [Abstract][Full Text] [Related]
10. Gene-environment interactions between HLA B7/A2, EBV antibodies are associated with MRI injury in multiple sclerosis.
Zivadinov R; Weinstock-Guttman B; Zorzon M; Uxa L; Serafin M; Bosco A; Bratina A; Maggiore C; Grop A; Tommasi MA; Srinivasaraghavan B; Ramanathan M
J Neuroimmunol; 2009 Apr; 209(1-2):123-30. PubMed ID: 19232441
[TBL] [Abstract][Full Text] [Related]
11. Frequency analysis of HLA-B7-restricted Epstein-Barr virus-specific cytotoxic T lymphocytes in patients with multiple sclerosis and healthy controls.
Gronen F; Ruprecht K; Weissbrich B; Klinker E; Kroner A; Hofstetter HH; Rieckmann P
J Neuroimmunol; 2006 Nov; 180(1-2):185-92. PubMed ID: 17023054
[TBL] [Abstract][Full Text] [Related]
12. A meta-analysis of interaction between Epstein-Barr virus and HLA-DRB1*1501 on risk of multiple sclerosis.
Xiao D; Ye X; Zhang N; Ou M; Guo C; Zhang B; Liu Y; Wang M; Yang G; Jing C
Sci Rep; 2015 Dec; 5():18083. PubMed ID: 26656273
[TBL] [Abstract][Full Text] [Related]
13. Association of Epstein-Barr virus infection with multiple sclerosis in India.
Pandit L; Malli C; D'Cunha A; Shetty R; Singhal B
J Neurol Sci; 2013 Feb; 325(1-2):86-9. PubMed ID: 23312038
[TBL] [Abstract][Full Text] [Related]
14. Multiple sclerosis and Epstein-Barr virus.
Levin LI; Munger KL; Rubertone MV; Peck CA; Lennette ET; Spiegelman D; Ascherio A
JAMA; 2003 Mar; 289(12):1533-6. PubMed ID: 12672770
[TBL] [Abstract][Full Text] [Related]
15. Epstein-barr virus gene expression, human leukocyte antigen alleles and chronic high viral loads in pediatric renal transplant patients.
Moran J; Carr M; Waters A; Boyle S; Riordan M; Connell J; Awan A; Hall W; Hassan J
Transplantation; 2011 Aug; 92(3):328-33. PubMed ID: 21685826
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus, cytomegalovirus, and multiple sclerosis susceptibility: A multiethnic study.
Langer-Gould A; Wu J; Lucas R; Smith J; Gonzales E; Amezcua L; Haraszti S; Chen LH; Quach H; James JA; Barcellos LF; Xiang AH
Neurology; 2017 Sep; 89(13):1330-1337. PubMed ID: 28855411
[TBL] [Abstract][Full Text] [Related]
17. HLA-DRB1 15:01 and Epstein-Barr virus in a multiple sclerosis patient with psoriasis, nasopharyngeal and breast cancers. Lessons for possible hidden links for autoimmunity and cancer.
Anagnostouli M; Anagnostoulis G; Katsavos S; Panagiotou M; Kararizou E; Davaki P
J Neurol Sci; 2014 Apr; 339(1-2):26-31. PubMed ID: 24576802
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr Virus and multiple sclerosis in a Spanish cohort: A two-years longitudinal study.
Domínguez-Mozo MI; López-Lozano L; Pérez-Pérez S; García-Martínez Á; Torrejón MJ; Arroyo R; Álvarez-Lafuente R
Front Immunol; 2022; 13():991662. PubMed ID: 36189297
[TBL] [Abstract][Full Text] [Related]
19. Relationship between HLA-DRB1* 11/15 genotype and susceptibility to multiple sclerosis in Iran.
Abolfazli R; Samadzadeh S; Sabokbar T; Siroos B; Armaki SA; Aslanbeiki B; Ghelman M; Taheri T; Shakoori A
J Neurol Sci; 2014 Oct; 345(1-2):92-6. PubMed ID: 25064442
[TBL] [Abstract][Full Text] [Related]
20. Serum concentration of immunoglobulin G-type antibodies against the whole Epstein-Barr nuclear antigen 1 and its aa35-58 or aa398-404 fragments in the sera of patients with systemic lupus erythematosus and multiple sclerosis.
Csuka D; Simon D; Hóbor R; Uray K; Prohászka Z; Bánlaki Z; Jani PK; Szilágyi Á; Hudecz F; Rajczy K; Beke G; Boros Major A; Tordai A; Illés Z; Berki T; Czirják L; Füst G
Clin Exp Immunol; 2013 Mar; 171(3):255-62. PubMed ID: 23379431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
